Potentials for Tetracyclines in the Treatment of COVID-19

Tetracyclines might be coming to help us to have some hope in a prophylaxis protocol for COVID-19. They work by Inhibition of bacterial protein synthesis by binding with the 30S and possibly the 50S ribosomal subunit of susceptible bacteria; they also cause alterations in the cytoplasmic membrane.

Tetracyclines are approved for treatment of
respiratory tract infections caused by Haemophilus influenzae (upper respiratory tract only),
Klebsiella spp. (lower respiratory tract only),
Mycoplasma pneumoniae (lower respiratory tract only),
Streptococcus pneumoniae, or Streptococcus pyogenes.

Tetracycline%20%28structural%20formula%29 » Potentials for Tetracyclines in the Treatment of COVID-19

TETRACYCLINE

Read more


Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download [2.11 MB]

Obaid

Pharmacist, CPHQ, CHQO, Quality Coordinator, Chemotherapy Preparation incharge. Graduated pharmacy school in 2009 I stood with my classmates as we recited the “Oath of a Pharmacist” in. There is one particular vow that stood out to me as we recited the Oath and I embrace this vow, “I will apply my knowledge, experience, and skills to the best of my ability to assure optimal outcomes for my patients.” I love being a pharmacist because it allows me to use my knowledge, abilities, and talents to improve patient outcomes in the community hospital in which I am employed as the pharmacy clinical coordinator.

>
%d bloggers like this: